- Category
- Micro (2024-25)
- Udyam number
- UDYAM-TN-07-0023507

Jan Med India Pharma Private Limited
About Jan Med India Pharma Private Limited
Data last updated:
Jan Med India Pharma Private Limited is a private limited company based in Erode, Tamil Nadu, India. It operates in the medicinal chemical and botanical products segment of the chemicals sector. It was incorporated on 03 November 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Coimbatore, under CIN U33100TZ2021PTC037476. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Thangaraj Sheela (Managing Director) and Manamohan.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at No.811P Gandhiji Street, Erode C Kasipalayam, Tamil Nadu, India – 638009.
As per the financials filed for FY 2025, the company reported a revenue of ₹23.22 Lakh, a growth of 70% compared to the previous year. For the same year it recorded a net profit of ₹84,848 (net margin 3.7%) and EBITDA of ₹1.22 Lakh (EBITDA margin 5.2%). Revenue has grown at a compounded annual rate (CAGR) of 352% over three years.
Jan Med India Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TN-07-0023507). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Recognitions & Rankings of Jan Med India Pharma
Contact details
Jan Med India Pharma Private Limited's registered office is in Erode, Tamil Nadu. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressNo.811P Gandhiji Street, Erode C Kasipalayam, Tamil Nadu, India – 638009
- IndustryChemicals, Medicinal Chemical & Botanical Products, Pharmaceuticals, Chemical Products
To see the full contact details of Jan Med India Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Jan Med India Pharma is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations |
To see the full business activity and turnover split of Jan Med India Pharma Private Limited, buy the company report.
Financials of Jan Med India Pharma Private Limited
FY 2024 filings availableJan Med India Pharma Private Limited reported revenue of ₹23.22 Lakh (up 70% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 352% over three years, including 70% growth in the latest year. EBITDA rose 16% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹1.22 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹84,848 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 5.2% | |||
| Net Profit Margin | 3.7% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Jan Med India Pharma Private Limited, buy the company report.
Board of directors of Jan Med India Pharma Private Limited
Jan Med India Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Thangaraj Sheela | Managing Director | 03 Nov 2021 | 5 Years 0 Months | Current |
| Manamohan | Director | 03 Nov 2021 | 5 Years 0 Months | Current |
Peer comparison
Jan Med India Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (manufacture of basic pharmaceutical products and pharmaceutical preparations), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Alestra Lifesciences Limited | ₹24 Lakh (FY 2025) | 488.0% | Kolkata, West Bengal, India | |||
| Oram Biochem Private Limited | ₹23.91 Lakh (FY 2025) | Pune, Maharashtra, India | ||||
| Strelitzia Pharmaceuticals Private Limited | ₹23.87 Lakh (FY 2025) | Ernakulam, Kerala, India | ||||
| Ista Life Care Private Limited | ₹23.81 Lakh (FY 2025) | 124.0% | Sangareddy, Telangana, India | |||
| Erotas Life Sciences Private Limited | ₹23.79 Lakh (FY 2025) | Hyderabad, Telangana, India | ||||
| Jan Med India Pharma Private Limitedthis company | ₹23.22 Lakh (FY 2025) | ₹84,848 | 3.7% | 70.0% | Erode, Tamil Nadu, India | |
| Terveysliv Pharmaceuticals Private Limited | ₹23.2 Lakh (FY 2025) | Surat, Gujarat, India | ||||
| Phytoveda Private Limited | ₹23.17 Lakh (FY 2025) | 167.0% | Mumbai, Maharashtra, India | |||
| Deepline Pharma Private Limited | ₹22.89 Lakh (FY 2025) | Delhi, India | ||||
| Goyal Industrial Park Private Limited | ₹22.62 Lakh (FY 2024) | -40.0% | Jaipur, Rajasthan, India | |||
| Navante Pharmaceuticals Private Limited | ₹22.6 Lakh (FY 2025) | Vijayawada, Andhra Pradesh, India |
To see the full peer comparison of Jan Med India Pharma Private Limited, buy the company report.
Auditor
Jan Med India Pharma Private Limited is audited by V.DEVARAJU & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| V.DEVARAJU & ASSOCIATES | FY 2023 | 0024174S |
Shareholding
The shareholding of Jan Med India Pharma Private Limited is on record for 2 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Jan Med India Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Jan Med India Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Jan Med India Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Jan Med India Pharma has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Jan Med India Pharma Private Limited, buy the company report.
Recent activity
Jan Med India Pharma Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Manamohan was appointed as Director on 03 Nov 2021.
Frequently asked questions
Jan Med India Pharma is an active private limited company based in Erode, Tamil Nadu, India. The company works in medicinal chemical and botanical products, within the chemicals industry. It was incorporated on 03 November 2021 (5+ years old) and is registered under CIN U33100TZ2021PTC037476.
Jan Med India Pharma has 2 current directors:
- Thangaraj Sheela - Managing Director
- Manamohan - Director
The latest financial statements of Jan Med India Pharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2022 are in the company report.
No. Jan Med India Pharma has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Jan Med India Pharma is U33100TZ2021PTC037476. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Jan Med India Pharma was incorporated on 03 November 2021, making it 5+ years old. It is registered with the Registrar of Companies, Coimbatore.
The peers of Jan Med India Pharma by revenue are Alestra Lifesciences Limited, Oram Biochem Private Limited, Strelitzia Pharmaceuticals Private Limited, Ista Life Care Private Limited, Erotas Life Sciences Private Limited and 5 more, all in the same principal business activity (manufacture of basic pharmaceutical products and pharmaceutical preparations).
Manamohan was appointed as Director on 03 Nov 2021. Thangaraj Sheela was appointed as Managing Director on 03 Nov 2021.
Yes, Jan Med India Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-TN-07-0023507).
The registered office of Jan Med India Pharma is at No.811P Gandhiji Street, Erode C Kasipalayam, Tamil Nadu, India – 638009.
Jan Med India Pharma operates in the chemicals industry, in the medicinal chemical and botanical products segment.

